| Code | Description | Claims | Beneficiaries | Total Paid |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
41,454 |
38,317 |
$3.81M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,761 |
2,600 |
$743K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,142 |
3,930 |
$728K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,153 |
1,939 |
$643K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,858 |
6,502 |
$136K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
596 |
538 |
$74K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,293 |
2,221 |
$65K |
| 90837 |
Psychotherapy, 53 minutes with patient |
575 |
326 |
$56K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
412 |
392 |
$26K |
| 0002A |
|
632 |
627 |
$18K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
393 |
349 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,970 |
6,186 |
$17K |
| 11721 |
|
647 |
627 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
405 |
372 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
395 |
355 |
$15K |
| 87631 |
|
505 |
491 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
10,397 |
9,352 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
132 |
108 |
$13K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
125 |
125 |
$12K |
| 0001A |
|
504 |
481 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
254 |
235 |
$11K |
| 90834 |
Psychotherapy, 45 minutes with patient |
90 |
64 |
$10K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
833 |
826 |
$10K |
| 80053 |
Comprehensive metabolic panel |
2,972 |
2,648 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
850 |
736 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,834 |
1,603 |
$7K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
258 |
101 |
$6K |
| 90686 |
|
1,507 |
1,493 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
83 |
69 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
454 |
415 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
26 |
26 |
$3K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
176 |
157 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
101 |
94 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
130 |
129 |
$3K |
| 0072A |
|
66 |
66 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$2K |
| 90461 |
|
250 |
237 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
420 |
396 |
$2K |
| 0071A |
|
52 |
52 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
25 |
25 |
$2K |
| 0004A |
|
53 |
52 |
$2K |
| 92557 |
|
12 |
12 |
$1K |
| 80061 |
Lipid panel |
195 |
186 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
68 |
68 |
$1K |
| 81001 |
|
924 |
834 |
$1K |
| 97161 |
|
18 |
18 |
$1K |
| 0064A |
|
28 |
28 |
$907.22 |
| 91322 |
|
14 |
13 |
$864.02 |
| 71045 |
Radiologic examination, chest; single view |
47 |
44 |
$652.97 |
| 86140 |
|
333 |
293 |
$637.73 |
| 90480 |
|
26 |
25 |
$636.24 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
21 |
12 |
$600.23 |
| 83605 |
|
237 |
208 |
$600.00 |
| 85027 |
|
239 |
215 |
$591.29 |
| 0031A |
|
19 |
19 |
$511.09 |
| 85610 |
|
248 |
164 |
$388.57 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
150 |
141 |
$336.43 |
| 87634 |
|
13 |
13 |
$334.77 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
14 |
12 |
$326.93 |
| 0124A |
|
12 |
12 |
$326.24 |
| 84484 |
|
104 |
92 |
$243.49 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
30 |
30 |
$165.37 |
| 83690 |
|
142 |
128 |
$150.27 |
| 96376 |
|
14 |
13 |
$147.89 |
| Q3014 |
Telehealth originating site facility fee |
12 |
12 |
$113.44 |
| 81025 |
|
71 |
69 |
$104.84 |
| 87660 |
|
13 |
12 |
$104.79 |
| 87510 |
|
13 |
12 |
$103.41 |
| 87480 |
|
13 |
12 |
$99.75 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$88.91 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$88.91 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
422 |
358 |
$88.68 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
724 |
632 |
$87.13 |
| 83880 |
|
13 |
13 |
$83.80 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
101 |
101 |
$64.85 |
| 90656 |
|
105 |
105 |
$44.22 |
| G0008 |
Administration of influenza virus vaccine |
15 |
15 |
$42.22 |
| 82805 |
|
14 |
13 |
$39.91 |
| 81003 |
|
71 |
65 |
$37.51 |
| 82248 |
|
64 |
62 |
$20.42 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$7.03 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
31 |
25 |
$1.81 |
| 90677 |
|
116 |
114 |
$1.68 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
367 |
308 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
183 |
136 |
$0.00 |
| 91300 |
|
1,023 |
970 |
$0.00 |
| 90670 |
|
139 |
125 |
$0.00 |
| 0753T |
|
46 |
42 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
175 |
99 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
360 |
144 |
$0.00 |
| 91307 |
|
128 |
126 |
$0.00 |
| J3490 |
Unclassified drugs |
194 |
137 |
$0.00 |
| 90698 |
|
90 |
78 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
148 |
118 |
$0.00 |
| 91306 |
|
26 |
26 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
286 |
262 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
184 |
157 |
$0.00 |
| 90680 |
|
13 |
13 |
$0.00 |
| 90697 |
|
52 |
52 |
$0.00 |
| A9270 |
Non-covered item or service |
39 |
32 |
$0.00 |
| 36416 |
|
21 |
13 |
$0.00 |
| 90651 |
|
40 |
39 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
67 |
54 |
$0.00 |
| 91303 |
|
15 |
15 |
$0.00 |